Ishares Nasdaq Biotechnology (IBB)

[ITMS]

Price Target On The NASDAQ BioTech ETF Revealed

As certain market sectors stall out, the biotechnology sector burst through its 2017 highs. This breakout will trigger a continued squeeze even higher on the iShares NASDAQ BioTech ETF $IBB. At a current price of $118.81, investors should expect further upside to a $133.00 target in the next month. Once there, investors should expect a sharp pull back and potential high for 2018. As a swing trader, I am patiently waiting to short that pivot high at $133.00 for a pull back to $114.50.





Gareth Soloway
InTheMoneyStocks